文献速递心脏核医学放射性药物与辐射防护

内脏脂肪表型与低脂联素血症与家族性血脂异常患者主动脉18F-FDG摄取相关

Visceral adipose tissue phenotype and hypoadiponectinemia are associated with aortic Fluorine-18 fluorodeoxyglucose uptake in patients with familial dyslipidemias.
PubMed 文献 · J Nucl Cardiol · 2021-01-26

本研究纳入40例家族性血脂异常患者(20例杂合子家族性高胆固醇血症和20例家族性混合型高脂血症)及20例非此类患者对照,通过血液脂联素检测和18F-FDG PET/CT量化腹部内脏与皮下脂肪体积及主动脉摄取。结果显示家族性混合型高脂血症患者内脏脂肪体积增加、代谢活性降低且脂联素水平更低,内脏脂肪体积是循环脂联素的主要决定因素,且脂联素与主动脉TBR相关;按内脏脂肪体积/代谢活性与脂联素聚类可区分主动脉TBR显著不同的两组。

要点

  • 家族性混合型高脂血症患者内脏脂肪体积增加、代谢活性降低且脂联素水平更低
  • 血清脂联素水平与主动脉TBR呈独立负相关
  • 内脏脂肪表型联合低脂联素血症可区分主动脉炎症水平不同的患者亚组

核心结论

  • 内脏脂肪表型(内脏脂肪体积增加和/或内脏脂肪高TBR)与低脂联素血症可能解释杂合子家族性高胆固醇血症与家族性混合型高脂血症患者之间动脉炎症水平的差异。

研究设计与样本

  • 本研究纳入40例家族性血脂异常患者(20例杂合子家族性高胆固醇血症和20例家族性混合型高脂血症)及20例非此类患者对照,进行血清脂联素检测和18F-FDG PET/CT成像,量化腹部内脏与皮下脂肪体积及脂肪和腹主动脉18F-FDG摄取。

主要发现

  • 家族性混合型高脂血症患者较杂合子家族性高胆固醇血症或对照组内脏脂肪体积增加(pANOVA=0.004)、皮下脂肪体积增加(pANOVA=0.003)、内脏脂肪代谢活性降低(pANOVA=0.0047)且脂联素水平更低(pANOVA=0.007)。
  • Log(血清脂联素)水平与主动脉TBR相关(b=-0.118,P=0.038)。
  • 中介分析显示内脏脂肪体积是循环脂联素的主要决定因素,该效应部分由内脏脂肪TBR介导。
  • 按内脏脂肪体积/TBR和血清脂联素对家族性血脂异常患者聚类,识别出两个主动脉TBR水平显著不同的患者簇(2.11±0.06 vs 1.89±0.05,P=0.012)。

临床怎么用

  • 在家族性血脂异常患者中,可关注内脏脂肪体积、内脏脂肪代谢活性及血清脂联素水平,以辅助评估动脉炎症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of adipose tissue (AT) in arterial inflammation in familial dyslipidaemias is poorly studied. We investigated the relationship between AT and arterial inflammation in patients with heterozygous familial hypercholesterolemia (heFH) and familial combined hyperlipidemia (FCH). METHODS AND RESULTS: A total of 40 patients (20 heFH/20 FCH) and a subgroup of 20 of non-heFH/FCH patients were enrolled. Participants underwent blood sampling for serum adipokine measurements and Fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT imaging. Abdominal visceral (VAT) and subcutaneous (SAT) AT volumes and AT and abdominal aorta 18F-FDG uptake were quantified. FCH patients had increased VAT (pANOVA = 0.004) and SAT volumes (pANOVA = 0.003), lower VAT metabolic activity (pANOVA = 0.0047), and lower adiponectin levels (pANOVA = 0.007) compared to heFH or the control group. Log(Serum adiponectin) levels were correlated with aortic TBR (b = - 0.118, P = 0.038). In mediation analysis, VAT volume was the major determinant of circulating adiponectin, an effect partly mediated via VAT TBR. Clustering of the population of heFH/FCH by VAT volume/TBR and serum adiponectin identified two distinct patient clusters with significant differences in aortic TBR levels (2.11 ± 0.06 vs 1.89 ± 0.05, P= 0.012). CONCLUSIONS: VAT phenotype (increased VAT volume and/or high VAT TBR) and hypoadiponectinemia may account for the observed differences in arterial inflammation levels between heFH and FCH patients.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Toutouzas K, Antonopoulos AS, Koutagiar I, et al. Visceral adipose tissue phenotype and hypoadiponectinemia are associated with aortic Fluorine-18 fluorodeoxyglucose uptake in patients with familial dyslipidemias. J Nucl Cardiol. 2021. PMID: 33501546. doi:10.1007/s12350-020-02472-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。